M. Custer

发表

Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer

M. Nishimura, P. Spiess, T. Clay, 1999, Pathology & Oncology Research.

Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice.

W. Travis, S. Rosenberg, J. Mulé, 1992, Journal of immunology.

Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applications.

S. Rosenberg, M. Lotze, Y. Kawakami, 1990, Human immunology.

T-cell Receptor Repertoire in Matched MARTi Peptide-. stimulated Peripheral Blood Lymphocytes and Tumor-infiltrating Lymphocytes

M. Nishimura, L. Rivoltini, D. Cole, 2006 .

T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.

M. Nishimura, L. Rivoltini, D. Cole, 1997, Cancer research.

Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: a possible approach to the immunotherapy of human tumors.

S. Rosenberg, M. Lotze, M. Custer, 1987, The Journal of surgical research.

Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes.

S. Rosenberg, P. Hwu, C. Smith, 1992, JIM - Journal of Immunological Methods.

Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor

R. M. Simpson, J. Barrett, J. C. Barrett, 2006, The Prostate.

Characterization of the functional specificity of a cloned T-cell receptor heterodimer recognizing the MART-1 melanoma antigen.

S. Rosenberg, M. Nishimura, Y. Kawakami, 1995, Cancer research.

Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue.

S. Rosenberg, M. Nishimura, P. Robbins, 1999, Journal of Immunology.

Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue.

Parkhurst, S. Rosenberg, M. Nishimura, 1999, Journal of immunology.

Identification of a T-cell receptor from a therapeutic murine T-cell clone.

S. Rosenberg, M. Nishimura, J. Mulé, 1997, Journal of immunotherapy.

A biologic assay for IL-4. Rapid fluorescence assay for IL-4 detection in supernatants and serum.

M. Lotze, M. Custer, 1990, JIM - Journal of Immunological Methods.

In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administration.

S. Rosenberg, M. Lotze, D. Nelson, 1987, Cancer research.

Intraperitoneal administration of interleukin-2 in patients with cancer.

S. Rosenberg, M. Lotze, M. Lotze, 1986, Archives of surgery.

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

R. Offringa, S. Rosenberg, K. Irvine, 1999, Cancer research.

The persistence of human peripheral lymphocytes, tumor infiltrating lymphocytes, and colon adenocarcinomas in immunodeficient mice.

J. Taubenberger, S. Rosenberg, J. Mulé, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations.

D. Goeddel, S. Rosenberg, T. Schall, 1996, Human gene therapy.

IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4.

M. Lotze, M. Custer, H. Stötter, 1991, Journal of immunology.

Localization of NaPi-1, a Na/Pi cotransporter, in rabbit kidney proximal tubules

A. Werner, B. Kaissling, H. Murer, 1993, Pflügers Archiv.

Localization of NaPi-1, a Na-Pi cotransporter, in rabbit kidney proximal tubules

R. Greger, E. Schlatter, H. Murer, 1993, Pflügers Archiv.

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.

S. Rosenberg, M. Lotze, Y. Kawakami, 1989, Journal of immunology.

Identification of a new gene product (diphor-1) regulated by dietary phosphate.

F. Verrey, H. Murer, M. Custer, 1997, American journal of physiology. Renal physiology.

Expression of Na-P(i) cotransport in rat kidney: localization by RT-PCR and immunohistochemistry.

B. Kaissling, H. Murer, M. Custer, 1994, The American journal of physiology.

Characterization of early aldosterone-induced RNAs identified in A6 kidney epithelia

F. Verrey, M. Custer, L. Mastroberardino, 1997, Pflügers Archiv.

Identification of a new gene product (diphor-1) regulated by dietary phosphate.

F. Verrey, H. Murer, M. Custer, 1997, The American journal of physiology.

Renal Na/Pi-cotransporters.

A. Werner, B. Kaissling, H. Murer, 1996, Kidney international.

Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.

S. Rosenberg, P. Hwu, M. Nishimura, 1999, Journal of immunology.

Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes.

Victor V Lobanenkov, J. Barrett, D. Loukinov, 2005, Cancer research.

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

S. Rosenberg, M. Lotze, C. Seipp, 1985, Journal of immunology.

Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.

Victor V Lobanenkov, J. Barrett, D. Loukinov, 2005, Cancer research.

MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.

S. Rosenberg, M. Nishimura, P. Robbins, 1999, Cancer research.

Global Expression Analysis of Cancer/Testis Genes in Uterine Cancers Reveals a High Incidence of BORIS Expression

A. Berchuck, S. Murphy, J. Barrett, 2007, Clinical Cancer Research.

Retroviral transduction of interferon-γ cDNA into a nonimmunogenic murinefibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor

S. Rosenberg, J. Mulé, N. Restifo, 1993, Cancer Immunology, Immunotherapy.

Normal viability of Kai1/Cd82 deficient mice

R. M. Simpson, J. Webster, L. Tessarollo, 2013, Molecular carcinogenesis.

T Cell‐Receptor V Gene Use by CD4+ Melanoma‐Reactive Clonal and Oligoclonal T‐Cell Lines

S. Rosenberg, M. Nishimura, A. Mixon, 1998, Journal of immunotherapy.

The N-terminal hexapeptide fragment of IGF II stimulates thymidine incorporation into fibroblasts.

U. Lutz, M. Custer, R. Humbel, 1992, Biochemical and biophysical research communications.

Cellular mechanisms of acute and chronic adaptation of rat renal P(i) transporter to alterations in dietary P(i).

B. Kaissling, M. Levi, H. Murer, 1994, The American journal of physiology.

Nephron localization of Na/SO42−-cotransport-related mRNA and protein

H. Murer, M. Custer, J. Biber, 1994, Pflügers Archiv.

Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.

S. Rosenberg, M. Lotze, M. Custer, 1990, Journal of biological response modifiers.

Immunolocalization of Na/SO4-cotransport (NaSi-1) in rat kidney

B. Kaissling, H. Murer, M. Custer, 1996, Pflügers Archiv.